1887

Chapter 7 : Innate Natural Killer Cell Responses to Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Innate Natural Killer Cell Responses to Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap07-1.gif /docserver/preview/fulltext/10.1128/9781555817671/9781555812911_Chap07-2.gif

Abstract:

This chapter describes and reviews the functions of natural killer (NK) cells, primarily from studies of their antitumor properties, and discusses recent advances in the understanding of NK cell responses in host defense against pathogens. The in vitro NK cell proliferative response to high concentrations of interleukin-2 (IL-2) is unlikely to be mimicked in vivo. The role of NK cells in infection is highlighted by the case of an adolescent woman with a selective NK cell deficiency in whom there were frequent, recurrent septicemic episodes due to uncontrolled viral infections, including cytomegalovirus (CMV), varicella-zoster virus, and herpes simplex virus. The NK cell compartment is not fully developed at birth, as indicated by lower natural killing by human cord blood lymphocytes and corroborated by studies on the ontogeny of NK cells in rodents. Classically, NK cells kill their targets by the triggered and directional release of preformed cytoplasmic granules containing perforin and granzymes, a process termed granule exocytosis. The role of NK cells in infection control is related to their receptors that regulate the natural killing function. The inhibitory receptors do not explain all aspects of NK cell specificity. As predicted by the two-receptor model, NK cell recognition also appears to involve activation receptors. The distribution of NK cells and recruitment therefore may be related to organ-specific differences in the NK cell effector mechanism controlling murine CMV (MCMV) replication.

Citation: Yokoyama W. 2004. Innate Natural Killer Cell Responses to Infection, p 133-156. In Kaufmann S, Medzhitov R, Gordon S (ed), The Innate Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555817671.ch7

Key Concept Ranking

Human immunodeficiency virus 1
0.50552666
Mitogen-Activated Protein Kinase Pathway
0.48390132
MHC Class I
0.41900495
0.50552666
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817671.chap7
1. Aderem, A.,, and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782 787.
2. Ahmad, A.,, E. Sharif-Askari,, L. Fawaz,, and J. Menezes. 2000. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J.Virol. 74: 7196 7203.
3. Akira, S. 2000. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12: 59 63.
4. Anderson, P.,, M. Caligiuri,, J. Ritz,, and S. F. Schlossman. 1989. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature 341: 159 162.
5. Andrews, D. M.,, C. E. Andoniou,, F. Granucci,, P. Ricciardi-Castagnoli,, and M. A. Degli- Esposti. 2001a. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2: 1077 1084.
6. Andrews, D. M.,, H. E. Farrell,, E. H. Densley,, A. A. Scalzo,, G. R. Shellam,, and M. A. Degli- Esposti. 2001b. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J. Immunol. 166: 1796 1802.
7. Arase, H.,, T. Saito,, J. H. Phillips,, and L. L. Lanier. 2001. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 167: 1141 1144.
8. Arase, H.,, E. S. Mocarski,, A. E. Campbell,, A. B. Hill,, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323 1326.
9. Arase, N.,, H. Arase,, S.Y. Park,, H. Ohno,, C. Ra,, and T. Saito. 1997. Association with FcR-γ is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1 + T cells. J. Exp. Med. 186: 1957-– 1963.
10. Bakker, A. B.,, R. M. Hoek,, A. Cerwenka,, B. Blom,, L. Lucian,, T. McNeil,, R. Murray,, L. H. Phillips,, J. D. Sedgwick,, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345 353.
11. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5: 503 510.
12. Bancroft, G. J.,, R. D. Schreiber,, and E. R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124: 5 24.
13. Bauer, S.,, V. Groh,, J. Wu,, A. Steinle,, J. H. Phillips,, L. L. Lanier,, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727 729.
14. Biassoni, R.,, C. Cantoni,, M. Falco,, S. Verdiani,, C. Bottino,, M. Vitale,, R. Conte,, A. Poggi,, A. Moretta,, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183: 645 650.
15. Biron, C. A.,, G. Sonnenfeld,, and R. M. Welsh. 1984. Interferon induces natural killer cell blastogenesis in vivo. J. Leukoc. Biol. 35: 31 37.
16. Biron, C.A.,, K. S. Byron,, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731 1735.
17. Biron, C. A.,, K. B. Nguyen,, G. C. Pien,, L. P. Cousens,, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189 220.
18. Bonavida, B.,, J. Katz,, and M. Gottlieb. 1986. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J. Immunol. 137: 1157 1163.
19. Born, T. L.,, L. A. Morrison,, D. J. Esteban,, T. VandenBos,, L. G. Thebeau,, N. Chen,, M. K. Spriggs,, J. E. Sims,, and R. M. Buller. 2000. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164: 3246 3254.
20. Bradley, M.,, A. Zeytun,, A. Rafi-Janajreh,, P. S. Nagarkatti,, and M. Nagarkatti. 1998. Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas− tumor cells. Blood 92: 4248 4255.
21. Braud, V. M.,, D. S. J. Allen,, C.A. O'Callaghan,, K. Söderström,, A. D'Andrea,, G. S. Ogg,, S. Lazetic,, N. T. Young,, J. I. Bell,, J. H. Phillips,, and A. J. McMichael. 1998. HLA-E binds to natural-killer-cell receptors CD94/NKG2A, B and C. Nature 391: 795 799.
22. Brombacher, F.,, A. Dorfmuller,, J. Magram,, W. J. Dai,, G. Kohler,, A. Wunderlin,, K. Palmer- Lehmann,, M. K. Gately,, and G. Alber. 1999. IL- 12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int.Immunol. 11: 325 332.
23. Brooks, C. G.,, M. Holscher,, and D. Urdal. 1985. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. J. Immunol. 135: 1145 1152.
24. Brown, M. G.,, A. A. Scalzo,, K. Matsumoto,, and W. M. Yokoyama. 1997. The natural killer gene complex— a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155: 53 65.
25. Brown, M. G.,, A. O. Dokun,, J.W. Heusel,, H. R. Smith,, D. L. Beckman,, E.A. Blattenberger,, C. E. Dubbelde,, L. R. Stone,, A. A. Scalzo,, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934 937.
26. Brumbaugh, K. M.,, B. A. Binstadt,, D. D. Billadeau,, R. A. Schoon,, C. J. Dick,, R. M. Ten,, and P. J. Leibson. 1997. Functional role for syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J. Exp. Med. 186: 1965 1974.>
27. Brumbaugh, K. M.,, B. A. Binstadt,, and P. J. Leibson. 1998. Signal transduction during NK cell activation: balancing opposing forces. Curr. Top. Microbiol. Immunol. 230: 103 122.
28. Bukowski, J. F.,, B. A. Woda,, S. Habu,, K. Okumura,, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131: 1531 1538.
29. Bukowski, J. F.,, B. A. Woda,, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119 128.
30. Bukowski, J. F.,, J. F. Warner,, G. Dennert,, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161: 40 52.
31. Carayannopoulos, L.,, O. Naidenko,, D. Fremont,, and W. M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169: 4079 4083.
32. Carnaud, C.,, D. Lee,, O. Donnars,, S. H. Park,, A. Beavis,, Y. Koezuka,, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647 4650.
33. Cella, M.,, F. Facchetti,, A. Lanzavecchia,, and M. Colonna. 2000. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1: 305 310.
34. Cerwenka, A.,, A. B. H. Bakker,, T. McClanahan,, J. Wagner,, J. Wu,, J. H. Phillips,, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721 727.
35. Chambers, W. H.,, N. L. Vujanovic,, A. B. DeLeo,, M. W. Olszowy,, R. B. Herberman,, and J. C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169: 1373 1389.
36. Cohen, G. B.,, R. T. Gandhi,, D. M. Davis,, O. Mandelboim,, B. K. Chen,, J. L. Strominger,, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661 671.
37. Colonna, M. 1997. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol. Rev. 155: 127 133.
38. Colonna, M.,, A. Krug,, and M. Cella. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14: 373 379.
39. Colucci, F.,, E. Schweighoffer,, E. Tomasello,, M. Turner,, J. R. Ortaldo,, E. Vivier,, V. L. Tybulewicz,, and J. P. Di Santo. 2002. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3: 288 294.
40. Cook, J. L.,, D. N. Ikle,, and B. A. Routes. 1995. Natural killer cell ontogeny in the athymic rat. Relationship between functional maturation and acquired resistance to E1A oncogene-expressing sarcoma cells. J. Immunol. 155: 5512 5518.
41. Cooper, M. A.,, J. E. Bush,, T. A. Fehniger,, J. B. VanDeusen,, R. E. Waite,, Y. Liu,, H. L. Aguila,, and M.A. Caligiuri. 2002. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100: 3633 3638.
42. Correa, I.,, and D. H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2: 61 71.
43. Correa, I.,, L. Corral,, and D. H. Raulet. 1994. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 24: 1323-– 1331.
44. Cosman, D.,, N. Fanger,, L. Borges,, M. Kubin,, W. Chin,, L. Peterson,, and M.-L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273 282.
45. Cosman, D.,, J. Mullberg,, C. L. Sutherland,, W. Chin,, R. Armitage,, W. Fanslow,, M. Kubin,, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123 133.
46. Cretney, E.,, M.A. Degli-Esposti,, E. H. Densley,, H. E. Farrell,, N. J. Davis-Poynter,, and M. J. Smyth. 1999. m144, a murine cytomegalovirus (MCMV)- encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190: 435 444.
47. Cuturi, M. C.,, I. Anegon,, F. Sherman,, R. Loudon,, S. C. Clark,, B. Perussia,, and G. Trinchieri. 1989. Production of hematopoietic colony stimulating factors by human natural killer cells. J. Exp. Med. 169: 569.
48. Dalod, M.,, T. P. Salazar-Mather,, L. Malmgaard,, C. Lewis,, C. Asselin-Paturel,, F. Briere,, G. Trinchieri,, and C. A. Biron. 2002. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195: 517 528.
49. Daniels, K. A.,, G. Devora,, W. C. Lai,, C. L. O'Donnell,, M. Bennett,, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to ly49h. J. Exp. Med. 194: 29 44.
50. Delano, M. L.,, and D.G. Brownstein. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J.Virol. 69: 5875 5877.
51. Depatie, C.,, E. Muise,, P. Lepage,, P. Gros,, and S. M. Vidal. 1997. High-resolution linkage map in the proximity of the host resistance locus CMV1. Genomics 39: 154 163.
52. Diefenbach, A.,, A. M. Jamieson,, S. D. Liu,, N. Shastri,, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119 126.
53. Diefenbach, A.,, E. Tomasello,, M. Lucas,, A. M. Jamieson,, J. K. Hsia,, E. Vivier,, and D. H. Raulet. 2002. Selective associations with signaling molecules determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3: 1142 1149.
54. DiSanto, J. P.,, W. Muller,, D. Guy-Grand,, A. Fischer,, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 92: 377 381.
55. Dokun, A. O.,, D.T. Chu,, L. Yang,, A. S. Bendelac,, and W. M. Yokoyama. 2001a. Analysis of in situ NK cell responses during viral infection. J. Immunol. 167: 5286 5293.
56. Dokun, A. O.,, S. Kim,, H. R. Smith,, H. S. Kang,, D. T. Chu,, and W. M. Yokoyama. 2001b. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951 956.
57. Dubois, S.,, J. Mariner,, T. A. Waldmann,, and Y. Tagaya. 2002. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 17: 537 547.
58. Duncan, G. S.,, H. W. Mittrucker,, D. Kagi,, T. Matsuyama,, and T.W. Mak. 1996. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184: 2043 2048.
59. Dunn, P. L.,, and R. J. North. 1991. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect. Immun. 59: 2892 2900.
60. Ebnet, K.,, M. Hausmann,, F. Lehmann-Grube,, A. Mullbacher,, M. Kopf,, M. Lamers,, and M. M. Simon. 1995. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J. 14: 4230 4239.
61. Fan, Q. R.,, E. O. Long,, and D. C. Wiley. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2: 452 460.
62. Farrell, H. E.,, H. Vally,, D. M. Lynch,, P. Fleming,, G. R. Shellam,, A. A. Scalzo,, and N. J. Davis- Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386: 510 514.
63. Fawaz, L. M.,, E. Sharif-Askari,, and J. Menezes. 1999. Up-regulation of NK cytotoxic activity via IL- 15 induction by different viruses: a comparative study. J. Immunol. 163: 4473 4480.
64. Ferlazzo, G.,, M. L. Tsang,, L. Moretta,, G. Melioli,, R. M. Steinman,, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343 351.
65. Forbes, C. A.,, M. G. Brown,, R. Cho,, G. R. Shellam,, W. M. Yokoyama,, and A. A. Scalzo. 1997. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics 41: 406 413.
66. Furukawa, H.,, K. Iizuka,, J. Poursine-Laurent,, N. Shastri,, and W. M. Yokoyama. 2002. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta(2)-microglobulin-deficient mice. J. Immunol. 169: 126 136.
67. George, T. C.,, L. H. Mason,, J. R. Ortaldo,, V. Kumar,, and M. Bennett. 1999. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162: 2035 2043.
68. Georgopoulos, K.,, M. Bigby,, J. H. Wang,, A. Molnar,, P. Wu,, S. Winandy,, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143 156.
69. Gerosa, F.,, B. Baldani-Guerra,, C. Nisii,, V. Marchesini,, G. Carra,, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327 333.
70. Gilfillan, S.,, E. L. Ho,, M. Cella,, W. M. Yokoyama,, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger natural killer cell activation and costimulation. Nat. Immunol. 3: 1150 1155.
71. Gosselin, J.,, A. TomoIu,, R. C. Gallo,, and L. Flamand. 1999. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94: 4210 4219.
72. Greenough, A. 1994. The TORCH screen and intrauterine infections. Arch. Dis. Childhood Fetal Neonatal Ed. 70: F163 F165.
73. Grimm, E. A.,, A. Mazumder,, H. Z. Zhang,, and S. A. Rosenberg. 1982. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155: 1823 1841.
74. Groh, V.,, R. Rhinehart,, J. Randolph-Habecker,, M. S. Topp,, S. R. Riddell,, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255 260.
75. Guidotti, L. G.,, and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19: 65 91.
76. Gunji, Y.,, N. L. Vujanovic,, J. C. Hiserodt,, R. B. Herberman,, and E. Gorelik. 1989. Generation and characterization of lymphokine-activated killer cells in mice. J. Immunol. 142: 1748 1754.
77. Hackett, J., Jr.,, G. C. Bosma,, M. J. Bosma,, M. Bennett,, and V. Kumar. 1986a. Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc. Natl. Acad. Sci. USA 83: 3427 3431.
78. Hackett, J., Jr.,, M. Tutt,, M. Lipscomb,, M. Bennett,, G. Koo,, and V. Kumar. 1986b. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J. Immunol. 136: 3124 3131.
79. Harty, J.T.,, and M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 3: 109 117.
80. Henkart, P.A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1: 343 346.
81. Herberman, R. 1982. NK Cells and Other Natural Effector Cells. Academic Press, New York, N.Y..
82. Herberman, R. B.,, M. E. Nunn,, and D. H. Lavrin. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16: 216.
83. Heusel, J.W.,, R. L. Wesselschmidt,, S. Shresta,, J. H. Russell,, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977 987.
84. Ho, E. L.,, J. W. Heusel,, M. G. Brown,, K. Matsumoto,, A. A. Scalzo,, and W. M. Yokoyama. 1998. Murine nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl. Acad. Sci. USA 95: 6320 6325.
85. Ho, E. L.,, L. N. Carayannopoulos,, J. Poursine- Laurent,, J. Kinder,, B. Plougastel,, H. R. C. Smith,, and W. M. Yokoyama. 2002. Co-stimulation of multiple NK cell activation receptors by NKG2D. J. Immunol. 169: 3667 3675.
86. Huang, S.,, W. Hendriks,, A. Althage,, S. Hemmi,, H. Bluethmann,, R. Kamijo,, J. Vilcek,, R. M. Zinkernagel,, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742 1745.
87. Hyodo, Y.,, K. Matsui,, N. Hayashi,, H. Tsutsui,, S. Kashiwamura,, H. Yamauchi,, K. Hiroishi,, K. Takeda,, Y. Tagawa,, Y. Iwakura,, N. Kayagaki,, M. Kurimoto,, H. Okamura,, T. Hada,, H. Yagita,, S. Akira,, K. Nakanishi,, and K. Higaashino. 1999. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162: 1662 1668.
88. Idris, A. H.,, H. R. C. Smith,, L. H. Mason,, J. H. Ortaldo,, A.A. Scalzo,, and W. M. Yokoyama. 1999. The natural killer cell complex genetic locus, Chok, encodes Ly49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96: 6330 6335.
89. Introne, W.,, R. E. Boissy,, and W. A. Gahl. 1999. Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol. Genet. Metab. 68: 283 303.
90. Inverardi, L.,, J. C. Witson,, S. A. Fuad,, R. T. Winkler-Pickett,, J. R. Ortaldo,, and F. H. Bach. 1991. CD3 negative “small agranular lymphocytes” are natural killer cells. J. Immunol. 146: 4048 4052.
91. Ishido, S.,, J. K. Choi,, B. S. Lee,, C. Wang,, M. DeMaria,, R. P. Johnson,, G. B. Cohen,, and J. U. Jung. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13: 365 374.
92. Jawahar, S.,, C. Moody,, M. Chan,, R. Finberg,, R. Geha,, and T. Chatila. 1996. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin. Exp. Immunol. 103: 408 413.
93. Jevremovic, D.,, D. D. Billadeau,, R. A. Schoon,, C. J. Dick,, B. J. Irvin,, W. Zhang,, L. E. Samelson,, R. T. Abraham,, and P. J. Leibson. 1999. Cutting edge: a role for the adaptor protein LAT in human NK cell-mediated cytotoxicity. J. Immunol. 162: 2453 2456.
94. Jiang, K.,, B. Zhong,, D. L. Gilvary,, B. C. Corliss,, E. Hong-Geller,, S. Wei,, and J. Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419 425.
95. Kagi, D.,, B. Ledermann,, K. Burki,, P. Seiler,, B. Odermatt,, K. J. Olsen,, E. R. Podack,, R. M. Zinkernagel,, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31 37.
96. Kane, L. P.,, P. G. Andres,, K. C. Howland,, A. K. Abbas,, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2: 37 44.
97. Karlhofer, F. M.,, M. M. Orihuela,, and W. M. Yokoyama. 1995. Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice. J. Exp. Med. 181: 1785 1795.
98. Karlhofer, F. M.,, R. K. Ribaudo,, and W. M. Yokoyama. 1992a. The interaction of Ly-49 with H-2Dd globally inactivates natural killer cell cytolytic activity. Trans. Assoc.Am. Phys. 105: 72 85.
99. Karlhofer, F. M.,, R. K. Ribaudo,, and W. M. Yokoyama. 1992b. MHC class I alloantigen specificity of Ly-49 + IL-2-activated natural killer cells. Nature 358: 66 70.
100. Kärre, K., 1985. Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis, p. 81-– 92. In R. B. Herberman, and D. M. Callewaert (ed.), Mechanisms of Cytotoxicity by NK Cells. Academic Press, Inc., Orlando, Fla..
101. Kärre, K.,, H. G. Ljunggren,, G. Piontek,, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675 678.
102. Kennedy, M. K.,, M. Glaccum,, S. N. Brown,, E. A. Butz,, J. L. Viney,, M. Embers,, N. Matsuki,, K. Charrier,, L. Sedger,, C. R. Willis,, K. Brasel,, P. J. Morrissey,, K. Stocking,, J. C. L. Schuh,, S. Joyce,, and J. J. Peschon. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771 780.
103. Kiessling, R.,, E. Klein,, and H. Wigzell. 1975. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells: specificity and distribution according to genotype. Eur. J. Immunol. 5: 112.
104. Kim, S.,, and W. M. Yokoyama. 1998. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement. Cell. Immunol. 183: 106 112.
105. Kim, S.,, K. Iizuka,, H. L. Aguila,, I. L. Weissman,, and W. M. Yokoyama. 2000. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97: 2731 2736.
106. Kloover, J. S.,, G. E. Grauls,, M. J. Blok,, C. Vink,, and C. A. Bruggeman. 2002. A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats. Arch.Virol. 147: 813 824.
107. Krmpotic, A.,, D. H. Busch,, I. Bubic,, F. Gebhardt,, H. Hengel,, M. Hasan,, A. A. Scalzo,, U. H. Koszinowski,, and S. Jonjic. 2002. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3: 529 535.
108. Kubota, A.,, S. Kubota,, H. E. Farrell,, N. Davis- Poynter,, and F. Takei. 1999. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 191: 145 151.
109. Lanier, L. L.,, J. H. Phillips,, J. Hackett, Jr.,, M. Tutt,, and V. Kumar. 1986. Natural killer cells: definition of a cell type rather than a function. J. Immunol. 137: 2735 2739.
110. Lanier, L. L.,, G. Yu,, and J. H. Phillips. 1989. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342: 803 805.
111. Lanier, L. L.,, B. Corliss,, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155: 145 154.
112. Lanier, L. L.,, B. Corliss,, J. Wu,, and J. H. Phillips. 1998a. Association of DAP12 with activating CD94/ NKG2C NK cell receptors. Immunity 8: 693 701.
113. Lanier, L. L.,, B. C. Cortiss,, J. Wu,, C. Leong,, and J. H. Phillips. 1998b. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703 707.
114. Lee, S. H.,, S. Girard,, D. Macina,, M. Busa,, A. Zafer,, A. Belouchi,, P. Gros,, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42 45.
115. Li, P.,, D. L. Morris,, B. E. Willcox,, A. Steinle,, T. Spies,, and R. K. Strong. 2001. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2: 443 451.
116. Li, P.,, G. McDermott,, and R. K. Strong. 2002. Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity 16: 77 86.
117. Ljunggren, H. G.,, and K. Kärre. 1990. In search of the “missing self ”: MHC molecules and NK cell recognition. Immunol.Today 11: 237 244.
118. Lodolce, J. P.,, D. L. Boone,, S. Chai,, R. E. Swain,, T. Dassopoulos,, S. Trettin,, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669 676.
119. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875 904.
120. Lopez-Botet, M.,, J. J. Perezvillar,, M. Carretero,, A. Rodriguez,, I. Melero,, T. Bellon,, M. Llano,, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155: 165 174.
121. Lowin, B.,, F. Beermann,, A. Schmidt,, and J. Tschopp. 1994. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91: 11571 11575.
122. Lusso, P.,, M. S. Malnati,, A. Garzino-Demo,, R.W. Crowley,, E. O. Long,, and R. C. Gallo. 1993. Infection of natural killer cells by human herpesvirus 6. Nature 362: 458 462.
123. Mandelboim, O.,, S. B. Wilson,, M. Vales-Gomez,, H. T. Reyburn,, and J. L. Strominger. 1997. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc. Natl. Acad. Sci. USA 94: 4604 4609.
124. Mandelboim, O.,, N. Lieberman,, M. Lev,, L. Paul,, T. I. Arnon,, Y. Bushkin,, D. M. Davis,, J. L. Strominger,, J.W. Yewdell,, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055 1060.
125. Manoussaka, M. S.,, R. J. Smith,, V. Conlin,, J. A. Toomey,, and C. G. Brooks. 1998. Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro. J. Immunol. 160: 2197 2206.
126. Mason, L. H.,, S. K. Anderson,, W. M. Yokoyama,, H. R. C. Smith,, R. Winklerpickett,, and J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184: 2119 2128.
127. Mason, L. H.,, J. Willettebrown,, S. K. Anderson,, P. Gosselin,, E. W. Shores,, P. E. Love,, J. R. Ortaldo,, and D. W. McVicar. 1998. Characterization of an associated 16-KDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 160: 4148 4152.
128. Medzhitov, R.,, and C. A. Janeway, Jr. 1998. Innate immune recognition and control of adaptive immune responses. Semin. Immunol. 10: 351 353.
129. Meraz, M. A.,, J. M. White,, K. C. Sheehan,, E. A. Bach,, S. J. Rodig,, A. S. Dighe,, D. H. Kaplan,, J. K. Riley,, A. C. Greenlund,, D. Campbell,, K. Carver-Moore,, R. N. DuBois,, R. Clark,, M. Arguet,, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431 442.
130. Michaelsson, J.,, A. Achour,, M. Salcedo,, A. Kase- Sjostrom,, J. Sundback,, R. A. Harris,, and K. Karre. 2000. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30: 300 307.
131. Moody, D. B.,, B. B. Reinhold,, M. R. Guy,, E. M. Beckman,, D. E. Frederique,, S.T. Furlong,, S. Ye,, V. N. Reinhold,, P. A. Sieling,, R. L. Modlin,, G. S. Besra,, and S. A. Porcelli. 1997. Structural requirements for glycolipid antigen recognition by CD1brestricted T cells. Science 278: 283 286.
132. Moody, D. B.,, T. Ulrichs,, W. Muhlecker,, D. C. Young,, S. S. Gurcha,, E. Grant,, J. P. Rosat,, M. B. Brenner,, C. E. Costello,, G. S. Besra,, and S. A. Porcelli. 2000. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404: 884 888.
133. Moretta, A.,, R. Biassoni,, C. Bottino,, D. Pende,, M. Vitale,, A. Poggi,, M. C. Mingari,, and L. Moretta. 1997. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155: 105 117.
134. Motyka, B.,, G. Korbutt,, M. J. Pinkoski,, J. A. Heibein,, A. Caputo,, M. Hobman,, M. Barry,, I. Shostak,, T. Sawchuk,, C. F. Holmes,, J. Gauldie,, and R. C. Bleackley. 2000. Mannose 6-phosphate/ insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103: 491 500.
135. Nakamura, M. C.,, P. A. Linnemeyer,, E. C. Niemi,, L. H. Mason,, J. R. Ortaldo,, J. C. Ryan,, and W. E. Seaman. 1999. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J. Exp. Med. 189: 493 500.
136. Nguyen, K. B.,, L. P. Cousens,, L. A. Doughty,, G. C. Pien,, J. E. Durbin,, and C. A. Biron. 2000. Interferon a/b-mediated inhibition and promotion of interferon-g: STAT1 resolves a paradox. Nat. Immunol. 1: 70 76.
137. Nguyen, K. B.,, T. P. Salazar-Mather,, M.Y. Dalod,, J. B. Van Deusen,, X. Q. Wei,, F. Y. Liew,, M. A. Caligiuri,, J. E. Durbin,, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-alphabeta, IL- 12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279 4287.
138. Ogasawara, K.,, S. Hida,, N. Azimi,, Y. Tagaya,, T. Sato,, T. Yokochifukuda,, T. A. Waldmann,, T. Taniguchi,, and S. Taki. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391: 700 703.
139. Ohteki, T.,, H. Yoshida,, T. Matsuyama,, G. S. Duncan,, T.W. Mak,, and P. S. Ohashi. 1998. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of NK1.1 + T cell receptor-αβ + (NK1 + T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187: 967 972.
140. Ohteki, T.,, T. Fukao,, K. Suzue,, C. Maki,, M. Ito,, M. Nakamura,, and S. Koyasu. 1999. Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J. Exp. Med. 189: 1981 1986.
141. Orange, J. S.,, and C. A. Biron. 1996a. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156: 1138 1142.
142. Orange, J. S.,, and C. A. Biron. 1996b. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746 4756.
143. Orange, J. S.,, B. Wang,, C. Terhorst,, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045 1056.
144. Orange, J. S.,, M. S. Fassett,, L. A. Koopman,, J. E. Boyson,, and J. L. Strominger. 2002. Viral evasion of natural killer cells. Nat. Immunol. 3: 1006 1012.
145. Orihuela, M.,, D. H. Margulies,, and W. M. Yokoyama. 1996. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc. Natl. Acad. Sci. USA 93: 11792 11797.
146. Pereira, R. A.,, A. Scalzo,, and A. Simmons. 2001. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 166: 5869 5873.
147. Peterson, E. J.,, J. L. Clements,, Z. K. Ballas,, and G. A. Koretzky. 1999. NK cytokine secretion and cytotoxicity occur independently of the SLP-76 adaptor protein. Eur. J. Immunol. 29: 2223 2232.
148. Philbrick, W. M.,, S. E. Maher,, M. M. Bridgett,, and A. L. Bothwell. 1990. A recombination event in the 5° flanking region of the Ly-6C gene correlates with impaired expression in the NOD, NZB and ST strains of mice. EMBO J. 9: 2485 2492.
149. Phillips, J. H.,, C. W. Chang,, J. Mattson,, J. E. Gumperz,, P. Parham,, and L. L. Lanier. 1996. CD94 and a novel associated protein (94ap) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5: 163 172.
150. Piccioli, D.,, S. Sbrana,, E. Melandri,, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335 341.
151. Pien, G. C.,, A. R. Satoskar,, K. Takeda,, S. Akira,, and C. A. Biron. 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFNgamma responses during viral infection. J. Immunol. 165: 4787 4791.
152. Radaev, S.,, B. Rostro,, A. G. Brooks,, M. Colonna,, and P. D. Sun. 2001. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15: 1039 1049.
153. Raulet, D. H.,, R. E. Vance,, and C.W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291 330.
154. Ravetch, J.V.,, and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457 491.
155. Ravetch, J. V.,, and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84 89.
156. Reyburn, H. T.,, O. Mandelboim,, M. Vales- Gomez,, D. M. Davis,, L. Pazmany,, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514 517.
157. Rook, A. H.,, H. Masur,, H. C. Lane,, W. Frederick,, T. Kasahara,, A. M. Macher,, J. Y. Djeu,, J. F. Manischewitz,, L. Jackson,, A. S. Fauci,, and G.V. Quinnan, Jr. 1983. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J. Clin. Invest. 72: 398 403.
158. Salazar-Mather, T. P.,, J. S. Orange,, and C. A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1-alpha (MIP-1-alpha)-dependent pathways. J. Exp. Med. 187: 1 14.
159. Salazar-Mather, T. P.,, T. A. Hamilton,, and C. A. Biron. 2000. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 105: 985 993.
160. Salazar-Mather, T. P.,, C. A. Lewis,, and C. A. Biron. 2002. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Invest. 110: 321 330.
161. Scalzo, A. A.,, N. A. Fitzgerald,, A. Simmons,, A. B. La Vista,, and G. R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171: 1469 1483.
162. Scalzo, A. A.,, N. A. Fitzgerald,, C. R. Wallace,, A. E. Gibbons,, Y. C. Smart,, R. C. Burton,, and G. R. Shellam. 1992. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149: 581 589.
163. Scalzo, A. A.,, P. A. Lyons,, N. A. Fitzgerald,, C. A. Forbes,, W. M. Yokoyama,, and G. R. Shellam. 1995. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex- associated loci Ly49 and musNKR-P1. Genomics 27: 435 441.
164. Schmidt, R. E.,, G. Bartley,, H. Levine,, S. F. Schlossman,, and J. Ritz. 1985. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. J. Immunol. 135: 1020 1025.
165. Schorle, H.,, T. Holtschke,, T. Hunig,, A. Schimpl,, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621 624.
166. Seaman, W. E.,, M. Sleisenger,, E. Eriksson,, and G. C. Koo. 1987. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138: 4539 4544.
167. Seki, H.,, Y. Ueno,, K. Taga,, A. Matsuda,, T. Miyawaki,, and N. Taniguchi. 1985. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11+ cell populations in cord blood and adult peripheral blood. J. Immunol. 135: 2351 2356.
168. Shellam, G. R.,, J. E. Allan,, J. M. Papadimitriou,, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA 78: 5104 5108.
169. Sjolin, H.,, E. Tomasello,, M. Mousavi-Jazi,, A. Bartolazzi,, K. Karre,, E. Vivier,, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195: 825 834.
170. Smith, H. R. C.,, F. M. Karlhofer,, and W. M. Yokoyama. 1994. Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153: 1068 1079.
171. Smith, H. R.,, H. H. Chuang,, L. L. Wang,, M. Salcedo,, J. W. Heusel,, and W. M. Yokoyama. 2000a. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med. 191: 1341 1354.
172. Smith, H. R.,, J.W. Heusel,, I. K. Mehta,, S. Kim,, B. G. Dorner,, O. V. Naidenko,, K. Iizuka,, H. Furukawa,, D. L. Beckman,, J. T. Pingel,, A. A. Scalzo,, D. H. Fremont,, and W. M. Yokoyama. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826 8831.
173. Smith, K. M.,, J. Wu,, A. B. Bakker,, J. H. Phillips,, and L. L. Lanier. 1998. Cutting edge: Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161: 7 10.
174. Smith, V. P.,, N.A. Bryant,, and A. Alcami. 2000b. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen.Virol. 81: 1223 1230.
175. Storkus, W. J.,, J. Alexander,, J. A. Payne,, J. R. Dawson,, and P. Cresswell. 1989. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86: 2361 2364.
176. Suzuki, H.,, G. S. Duncan,, H. Takimoto,, and T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185: 499 505.
177. Takeda, K.,, H. Tsutsui,, T. Yoshimoto,, O. Adachi,, N. Yoshida,, T. Kishimoto,, H. Okamura,, K. Nakanishi,, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383 390.
178. Tay, C. H.,, and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267 275.
179. Tomasec, P.,, V. M. Braud,, C. Rickards,, M. B. Powell,, B. P. McSharry,, S. Gadola,, V. Cerundolo,, L. K. Borysiewicz,, A. J. McMichael,, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287: 1031.
180. Tomasello, E.,, C. Cant,, H. J. Buhring,, F. Vely,, P. Andre,, M. Seiffert,, A. Ullrich,, and E. Vivier. 2000a. Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur. J. Immunol. 30: 2147 2156.
181. Tomasello, E.,, P.-O. Desmoulins,, K. Chemin,, S. Guia,, H. Cremer,, J. Ortaldo,, P. Love,, D. Kaiserlian,, and E. Vivier. 2000b. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13: 355 364.
182. Tormo, J.,, K. Natarajan,, D. H. Margulies,, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623 631.
183. Tortorella, D.,, B. E. Gewurz,, M. H. Furman,, D. J. Schust,, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18: 861 926.
184. Tough, D. F.,, P. Borrow,, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947 1950.
185. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187 376.
186. Tripp, C. S.,, S. F. Wolf,, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90: 3725 3729.
187. Tripp, C. S.,, M. K. Gately,, J. Hakimi,, P. Ling,, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice.Reversal by IFN-gamma. J. Immunol. 152: 1883-– 1887.
188. Tsunobuchi, H.,, H. Nishimura,, F. Goshima,, T. Daikoku,, H. Suzuki,, I. Nakashima,, Y. Nishiyama,, and Y. Yoshikai. 2000. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Virology 275: 57 66.
189. Ulbrecht, M.,, S. Martinozzi,, M. Grzeschik,, H. Hengel,, J. W. Ellwart,, M. Pla,, and E. H. Weiss. 2000. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164: 5019 5022.
190. Unanue, E. R. 1997. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9: 35 43.
191. Vance, R. E.,, D. M. Tanamachi,, T. Hanke,, and D. H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27: 3236 3241.
192. Vance, R. E.,, J. R. Kraft,, J. D. Altman,, P. E. Jensen,, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841 1848.
193. Vance, R. E.,, A. M. Jamieson,, and D. H. Raulet. 1999. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190: 1801 1812.
194. Viver, E.,, A. J. da Silva,, M. Ackerly,, H. Levine,, C. E. Rudd,, and P. Anderson. 1993. Association of a 70-kDa tyrosine phosphoprotein with the CD16: zeta:gamma complex expressed in human natural killer cells. Eur. J. Immunol. 23: 1872-– 1876
195. Waldmann, T. A.,, and Y. Tagaya. 1999. The multi-faceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17: 19 49.
196. Walsh, C. M.,, M. Matloubian,, C. C. Liu,, R. Ueda,, C. G. Kurahara,, J. L. Christensen,, M.T. Huang,, J. D. Young,, R. Ahmed,, and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91: 10854 10858.
197. Wang, B.,, C. Biron,, J. She,, K. Higgins,, M. J. Sunshine,, E. Lacy,, N. Lonberg,, and C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. USA 91: 9402 9406.
198. Wang, B. P.,, G. A. Hollander,, A. Nichogiannopoulou,, S. J. Simpson,, J. S. Orange,, J. C. Gutierrezramos,, S. J. Burakoff,, C. A. Biron,, and C. Terhorst. 1996. Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny. Int. Immunol. 8: 939 949.
199. Wang, L. L.,, D.T. Chu,, A. O. Dokun,, and W. M. Yokoyama. 2000. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164: 5215 5220.
200. Welsh, R. M.,, P. L. Dundon,, E. E. Eynon,, J. O. Brubaker,, G. C. Koo,, and C. L. O'Donnell. 1990. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1). Nat. Immun. Cell Growth Regul. 9: 112 120.
201. Willerford, D. M.,, J. Chen,, J. A. Ferry,, L. Davidson,, A. Ma,, and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521 530.
202. Wu, J.,, Y. Song,, A. B. Bakker,, S. Bauer,, T. Spies,, L. L. Lanier,, and J. H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285: 730 732.
203. Wu, J.,, H. Cherwinski,, T. Spies,, J. H. Phillips,, and L. L. Lanier. 2000. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192: 1059 1068.
204. Yewdell, J.W.,, and A. B. Hill. 2002. Viral interference with antigen presentation. Nat.Immunol. 3: 1019 1025.
205. Yokoyama, W. M. 1995. Natural killer cell receptors. Curr. Opin. Immunol. 7: 110 120.
206. Yokoyama, W. M. 1997. What goes up must come down: the emerging spectrum of inhibitory receptors. J. Exp. Med. 186: 1803 1808.
207. Yokoyama, W. M. 1999. Natural killer cells, p. 575-– 603. In W. E. Paul (ed.), Fundamental Immunology. Lippincott-Raven, New York, N.Y..
208. Yokoyama, W. M. 2000. Now you see it, now you don't! Nat. Immunol. 1: 95 97.
209. Yokoyama, W. M.,, and B. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3: 304 316.
210. Zamai, L.,, M. Ahmad,, I. M. Bennett,, L. Azzoni,, E. S. Alnemri,, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188: 2375 2380.
211. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195: F9 F14.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error